Profile picture

Doctor Fangfang Wang

Peking University Third Hospital, Beijing (China)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
Presentation
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources